FindTrial
Sign In

RETROSPECTIVE OBSERVATIONAL STUDY OF BRAF AND PIK3CA MUTATION IN INDIAN PATIENTS WITH COLORECTAL CANCERâ??

AN EPIDEMIOLOGICAL STUDY TO EVALUATE THE PREVALENCE OF BRAF AND PIK3CA MUTATION IN INDIAN PATIENTS WITH COLORECTAL CANCERâ??

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2016/06/006989
Enrollment
280
Registered
2016-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Colorectal Cancer Health Condition 2: C189- Malignant neoplasm of colon, unspecified

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of age >= 18years Diagnosed case of CRC with availability of representative tumor specimen for genetic analysis, from the biopsy sample

Exclusion criteria

Exclusion criteria: Blocks not available for analysis Clinical data not available in the database

Design outcomes

Primary

MeasureTime frame
BRAF PI3KCA mutation status in colorectal cancerTimepoint: 1 year—

Secondary

MeasureTime frame
Prevalence of different types of BRAF mutation Prevalence of BRAF PI3KCA mutations in age cohorts (â?¤ 40yrs and â?¥ 60yrs) Prevalence of BRAF, PI3KCA mutations in left sided and right sided cancers Timepoint: 1 year—

Countries

India

Contacts

Public ContactVikas Ostwal

Tata Memorial Hospital

dr.vikas.ostwal@gmail.com9702288801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026